Corpus Intelligence EBITDA Bridge — CALLAWAY DISTRICT HOSPITAL 2026-04-27 08:37 UTC
EBITDA Bridge — CALLAWAY DISTRICT HOSPITAL
CCN 281335 | NE | 12 beds | Current EBITDA $673K → Pro Forma $1.3M (+$638K)
🛡️ Public data only — no PHI permitted on this instance.
EBITDA BRIDGE  ·  CCN 281335

CALLAWAY DISTRICT HOSPITAL
value-creation walk.

7-lever RCM bridge from current EBITDA to pro-forma — denial / underpay / DAR / coding / contract / cost discipline / cash acceleration. Each lever shows current vs benchmark target with data provenance.

$12.1M
Net Revenue HCRIS
$673K
Current EBITDA COMPUTED
+$638K
RCM EBITDA Uplift
$1.3M
Pro Forma EBITDA
+529bps
Margin Improvement
$463K
WC Released (1x)

Bridge Realization Estimate

ML model predicts what fraction of the bridge is achievable (accuracy: 60%, n=5,839)

61%
Realization (C)
$638K
Modeled Uplift
$386K
Risk-Adjusted
-$251K
Execution Discount
Occupancy RateLower Occupancy Rate reduces execution likelihood
Commercial Payer %Higher Commercial Payer % increases execution like
Net-to-Gross RatioHigher Net-to-Gross Ratio reduces execution likeli
Bed CountHigher Bed Count increases execution likelihood
Revenue per BedLower Revenue per Bed reduces execution likelihood

Expected realization: 61% of modeled bridge. Strengths: Commercial Payer %, Bed Count. Risks: Occupancy Rate, Net-to-Gross Ratio. Risk-adjusted uplift: $0.4M (vs $0.6M modeled).

EBITDA Bridge — 7 RCM Levers

Each bar shows the annual EBITDA impact at full run-rate. Revenue levers increase top-line; cost levers reduce operating expense; cash acceleration releases working capital. Calibrated to published research bands (Denial 12%→5% = $8-15M on $400M NPR).

Cost to Collect
Cost Savings | 12mo ramp
$241K
+200bp
Denial Rate Reduction
Revenue | 12mo ramp
$240K
+199bp
A/R Days Reduction
Cash Accel | 9mo ramp
$147K
+122bp
Clean Claim Rate
Cost Savings | 6mo ramp
$10K
+8bp
Total EBITDA Impact$638K

Lever Detail

Each value shows its data source. SELLER = seller data room, DEFAULT = model default, BENCHMARK = P75 peer benchmark.

LeverCurrentTargetRevenueCostEBITDAWCRamp
Cost to Collect4.5% DEFAULT2.5% BENCHMARK$0$241K$241K$012mo
Denial Rate Reduction12.0% DEFAULT6.5% BENCHMARK$232K$8K$240K$012mo
A/R Days Reduction52.00 DEFAULT38.00 BENCHMARK$37K$110K$147K$463K9mo
Clean Claim Rate88.0% DEFAULT96.0% BENCHMARK$0$10K$10K$06mo
Net Collection Rate93.5% DEFAULT80.3% BENCHMARK$0$0$0$018mo
CDI / Case Mix Index135.0% DEFAULT142.0% BENCHMARK$0$0$0$018mo

Implementation Timing Curve

Linear ramp to full run-rate per lever. Month 0 = close date. Partners should expect 60-70% of total uplift realized by month 12.

LeverM0M3M6M9M12M18M24M36
Cost to Collect$0$60K$121K$181K$241K$241K$241K$241K
Denial Rate Reduction$0$60K$120K$180K$240K$240K$240K$240K
A/R Days Reduction$0$49K$98K$147K$147K$147K$147K$147K
Clean Claim Rate$0$5K$10K$10K$10K$10K$10K$10K
Cumulative$0$174K$348K$517K$638K$638K$638K$638K

Returns Sensitivity (IRR / MOIC)

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Green = exceeds 20% IRR hurdle. Amber = 15-20%. Red = below hurdle or loss. RCM uplift of $638K is added at exit.

Entry \ Exit9.0x10.0x11.0x11.5x12.0x
8.0x65% / 12.2x69% / 13.9x73% / 15.6x75% / 16.4x77% / 17.3x
9.0x60% / 10.4x64% / 12.0x68% / 13.5x70% / 14.3x72% / 15.0x
10.0x55% / 9.1x60% / 10.4x64% / 11.8x66% / 12.5x68% / 13.2x
11.0x51% / 8.0x56% / 9.2x60% / 10.4x62% / 11.1x64% / 11.7x
12.0x48% / 7.0x52% / 8.2x56% / 9.3x58% / 9.9x60% / 10.4x

Covenant Headroom (at 10x Entry, 6.5x Max Leverage)

8.5x
Entry Leverage
4.3x
Pro Forma Leverage
2.2x
Headroom (turns)
33%
EBITDA Cushion

Pro forma EBITDA can decline 33% before the 6.5x covenant trips. RCM uplift reduces leverage from 8.5x to 4.3x, adding 4.1 turns of cushion.

5-Year Value Creation Waterfall

EBITDA trajectory: 3% organic growth + RCM uplift ramp (full run-rate at month 18).

Base EBITDARCM UpliftTotalMargin
Entry$673K$673K5.6%
Year 1$693K+$425K$1.1M9.3%
Year 2$714K+$638K$1.4M11.2%
Year 3$735K+$638K$1.4M11.4%
Year 4$757K+$638K$1.4M11.6%
Year 5$780K+$638K$1.4M11.8%
$6.7M
Entry EV (10x)
$15.6M
Exit EV (11x)
$8.9M
Value Created
$1.4M
Exit EBITDA
$1.1M
Organic Growth
$6.4M
RCM Value Creation
$1.4M
Multiple Expansion

Achievement Sensitivity

What if we only achieve a fraction of each lever? 50% = conservative, 75% = base management case, 100% = plan, 120% = stretch.

Lever50%75%100%120%
Cost to Collect$121K$181K$241K$289K
Denial Rate Reductio$120K$180K$240K$288K
A/R Days Reduction$73K$110K$147K$176K
Clean Claim Rate$5K$7K$10K$12K
Total$319K$478K$638K$765K

Peer Context — Where This Hospital Sits

Key metrics vs 54 size-matched peers. Low percentile on margin/efficiency metrics = more room for improvement = larger bridge opportunity.

MetricHospitalP25P50P75Percentile
Op Margin5.6%-13.4%-7.4%-0.3%
P87
Net-to-Gross80.3%67.3%72.5%80.3%
P72
Occupancy17.3%9.6%16.1%21.9%
P54
Rev/Bed$1.0M$728K$1.2M$1.7M
P39
Exp/Bed$949K$729K$1.3M$1.7M
P30

Bridge Methodology

Coefficients calibrated to published research bands: denial 12%→5% = $8-15M on $400M NPR. Current metrics estimated from HCRIS public data and ML predictions. Target metrics set at P75 peer benchmarks with 60% gap closure assumption. Revenue levers use NPR × delta × avoidable share. Cost levers use claims volume × cost per reworked claim. Working capital from AR reduction is one-time cash (not included in recurring EBITDA). Returns assume 5.5x leverage, 3% organic growth, 10%/yr debt paydown.

Data: HCRIS FY2022 | 6,123 hospitalsSources: HCRISML